OTC Markets OTCPK - Delayed Quote USD
QHSLab, Inc. (USAQ)
0.2475
+0.0055
+(2.27%)
As of 10:44:45 AM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,288.7580
2,131.9260
1,408.9950
1,243.1860
1,414.4210
Cost of Revenue
787.0820
774.0360
615.3880
623.6670
743.6730
Gross Profit
1,501.6760
1,357.8900
793.6070
619.5190
670.7480
Operating Expense
1,321.5810
1,152.1520
1,033.7650
1,180.0580
1,173.0060
Operating Income
180.0950
205.7380
-240.1580
-560.5390
-502.2580
Net Non Operating Interest Income Expense
-500.4960
-465.0550
-230.4940
-433.4420
-246.4900
Other Income Expense
--
0.0780
2.2900
-2.0200
-21.4280
Pretax Income
-320.3230
-259.2390
-468.3620
-996.0010
-770.1760
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-320.3230
-259.2390
-468.3620
-996.0010
-770.1760
Diluted NI Available to Com Stockholders
-320.3230
-259.2390
-468.3620
-996.0010
-770.1760
Basic EPS
-0.04
-0.03
-0.05
-0.11
-0.10
Diluted EPS
-0.04
-0.03
-0.05
-0.11
-0.10
Basic Average Shares
10,616.8580
10,288.4580
9,416.7680
8,997.1290
7,861.0770
Diluted Average Shares
10,616.8580
10,288.4580
9,416.7680
8,997.1290
7,861.0770
Total Operating Income as Reported
180.0950
205.7380
-240.1580
-560.5390
-502.2580
Total Expenses
2,108.6630
1,926.1880
1,649.1530
1,803.7250
1,916.6790
Net Income from Continuing & Discontinued Operation
-320.3230
-259.2390
-468.3620
-996.0010
-770.1760
Normalized Income
-320.3230
-259.2390
-468.3620
-993.9810
-748.7480
Interest Expense
500.4960
465.0550
230.4940
433.4420
246.4900
Net Interest Income
-500.4960
-465.0550
-230.4940
-433.4420
-246.4900
EBIT
180.1730
205.8160
-237.8680
-562.5590
-523.6860
EBITDA
326.7470
352.3910
-91.2930
-434.6000
-487.6300
Reconciled Cost of Revenue
712.6200
699.5730
540.9250
567.8200
743.6730
Reconciled Depreciation
146.5740
146.5750
146.5750
127.9590
36.0560
Net Income from Continuing Operation Net Minority Interest
-320.3230
-259.2390
-468.3620
-996.0010
-770.1760
Total Unusual Items Excluding Goodwill
--
--
0
-2.0200
-21.4280
Total Unusual Items
--
--
0
-2.0200
-21.4280
Normalized EBITDA
326.7470
352.3910
-91.2930
-432.5800
-466.2020
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 5/22/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
STJO St. Joseph, Inc.
0.0310
-8.82%
IGNT Ingen Technologies, Inc.
0.0000
0.00%
LNMG Linike Medical Group Ltd.
0.0050
-16.67%
FZMD Fuse Medical, Inc.
0.0620
+1.64%
KLYG Kelyniam Global, Inc.
0.1400
+3.78%
CYDX CYduct Diagnostics, Inc.
0.4880
+140.28%
BINP Bionoid Pharma Inc.
0.1100
0.00%
MHTX Manhattan Scientifics, Inc.
0.0001
0.00%
DYNT Dynatronics Corporation
0.0810
-0.12%
ADMT ADM Tronics Unlimited, Inc.
0.0500
-20.63%